2f9u

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2f9u" size="350" color="white" frame="true" align="right" spinBox="true" caption="2f9u, resolution 2.60&Aring;" /> '''HCV NS3 protease dom...)
Line 4: Line 4:
==Overview==
==Overview==
-
Prolonged hepatitis C infection is the leading cause for cirrhosis of the, liver and hepatocellular carcinoma. The etiological agent HCV virus codes, a single polyprotein of approximately 3000 amino acids that is processed, with the help of a serine protease NS3A to produce structural and, non-structural proteins required for viral replication. Inhibition of NS3, protease can potentially be used to develop drugs for treatment of HCV, infections. Herein, we report the development of a series of novel NS3, serine protease inhibitors derived from 2-aza-bicyclo[2.2.1]-heptane, carboxylic acid with potential therapeutic use for treatment of HCV, infections.
+
Prolonged hepatitis C infection is the leading cause for cirrhosis of the liver and hepatocellular carcinoma. The etiological agent HCV virus codes a single polyprotein of approximately 3000 amino acids that is processed with the help of a serine protease NS3A to produce structural and non-structural proteins required for viral replication. Inhibition of NS3 protease can potentially be used to develop drugs for treatment of HCV infections. Herein, we report the development of a series of novel NS3 serine protease inhibitors derived from 2-aza-bicyclo[2.2.1]-heptane carboxylic acid with potential therapeutic use for treatment of HCV infections.
==About this Structure==
==About this Structure==
Line 15: Line 15:
[[Category: Butkiewicz, N.]]
[[Category: Butkiewicz, N.]]
[[Category: Girijavallabhan, V.]]
[[Category: Girijavallabhan, V.]]
-
[[Category: Njoroge, F.G.]]
+
[[Category: Njoroge, F G.]]
[[Category: Pichardo, J.]]
[[Category: Pichardo, J.]]
-
[[Category: Prongay, A.J.]]
+
[[Category: Prongay, A J.]]
[[Category: Venkatraman, S.]]
[[Category: Venkatraman, S.]]
[[Category: Wu, W.]]
[[Category: Wu, W.]]
Line 27: Line 27:
[[Category: ns3 protease]]
[[Category: ns3 protease]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jan 29 19:31:30 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:19:12 2008''

Revision as of 15:19, 21 February 2008


2f9u, resolution 2.60Å

Drag the structure with the mouse to rotate

HCV NS3 protease domain with NS4a peptide and a ketoamide inhibitor with a P2 norborane

Overview

Prolonged hepatitis C infection is the leading cause for cirrhosis of the liver and hepatocellular carcinoma. The etiological agent HCV virus codes a single polyprotein of approximately 3000 amino acids that is processed with the help of a serine protease NS3A to produce structural and non-structural proteins required for viral replication. Inhibition of NS3 protease can potentially be used to develop drugs for treatment of HCV infections. Herein, we report the development of a series of novel NS3 serine protease inhibitors derived from 2-aza-bicyclo[2.2.1]-heptane carboxylic acid with potential therapeutic use for treatment of HCV infections.

About this Structure

2F9U is a Protein complex structure of sequences from Hepatitis c virus with and as ligands. Full crystallographic information is available from OCA.

Reference

Novel inhibitors of hepatitis C NS3-NS4A serine protease derived from 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid., Venkatraman S, Njoroge FG, Wu W, Girijavallabhan V, Prongay AJ, Butkiewicz N, Pichardo J, Bioorg Med Chem Lett. 2006 Mar 15;16(6):1628-32. Epub 2006 Jan 18. PMID:16413182

Page seeded by OCA on Thu Feb 21 17:19:12 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools